Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.

Phytosterols: From Preclinical Evidence to Potential Clinical Applications / Salehi, B.; Quispe, C.; Sharifi-Rad, J.; Cruz-Martins, N.; Nigam, M.; Mishra, A. P.; Konovalov, D. A.; Orobinskaya, V.; Abu-Reidah, I. M.; Zam, W.; Sharopov, F.; Venneri, T.; Capasso, R.; Kukula-Koch, W.; Wawruszak, A.; Koch, W.. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 11:(2021), p. 599959. [10.3389/fphar.2020.599959]

Phytosterols: From Preclinical Evidence to Potential Clinical Applications

Venneri T.;Capasso R.;
2021

Abstract

Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.
2021
Phytosterols: From Preclinical Evidence to Potential Clinical Applications / Salehi, B.; Quispe, C.; Sharifi-Rad, J.; Cruz-Martins, N.; Nigam, M.; Mishra, A. P.; Konovalov, D. A.; Orobinskaya, V.; Abu-Reidah, I. M.; Zam, W.; Sharopov, F.; Venneri, T.; Capasso, R.; Kukula-Koch, W.; Wawruszak, A.; Koch, W.. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 11:(2021), p. 599959. [10.3389/fphar.2020.599959]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/835690
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 220
  • ???jsp.display-item.citation.isi??? 182
social impact